Eton Pharmaceuticals, Inc. (ETON): auditor change — Eton Pharmaceuticals dismisses auditor Crowe, appoints Grant Thornton

Eton Pharmaceuticals, Inc.

Effective June 13, 2025, Eton dismissed Crowe LLP as its independent auditor.
No disagreements or reportable events occurred during Crowe's tenure (fiscal year 2024).
Audit Committee appointed Grant Thornton LLP as new auditor for fiscal year 2025.
Crowe's audit report for FY 2024 was unqualified; no adverse opinions or modifications.
Company provided Crowe with disclosures; Crowe's letter filed as Exhibit 16.1.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Eton Pharmaceuticals, Inc. engaged Grant Thornton LLP as its auditor.

Action: engagement
Auditor: Grant Thornton LLP

Exact text from the filing

On June 13, 2025, the Audit Committee approved the appointment of Grant Thornton LLP ("Grant Thornton") as the Company’s new independent registered public accounting firm for the Company's fiscal year ended December 31, 2025.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Eton Pharmaceuticals, Inc. dismissed Crowe LLP as its auditor.

Action: dismissal
Auditor: Crowe LLP
Successor: Grant Thornton LLP

Exact text from the filing

On June 13, 2025, the Company dismissed Crowe LLP as the Company’s independent registered public accounting firm, effective June 13, 2025.

View on SEC.gov

Browse all auditor changes →

Eton Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-25-020916

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.